Cambridge Nutranostics Ltd: Cambridge Nutranostics has developed a point-of-care prototype of OCCL test for testing blood plasma oxygen to monitor health in post stroke and TIA patients for dementia prevention
CAMBRIDGE, England, April 6, 2022 /PRNewswire/ -- Cambridge Nutranostics Ltd, CNL, http://occltest.com has begun validation in clinic of its first test prototype to assess and monitor plasma
United Kingdom Kostenloser Wertpapierhandel Ivan Petyaev Alexey Shulepov Prnewswire Cambridge Nutranostics Ltd Cambridge University
Source: finanznachrichten.de